Related Experiment Video
Updated: Oct 30, 2025

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
Published on: May 15, 2021
A Rare Cause of Drug-Induced Pancytopenia: Trimethoprim-Sulfamethoxazole-Induced Pancytopenia
Khalid Sawalha1, Philip T Sobash1, Gilbert-Roy Kamoga1
1Internal Medicine Division, White River Health System, Batesville, AR 72501, USA.
Abstract:
Pancytopenia is a decrease across cellular hematological lines. Many different etiologies can cause this clinical picture including viral and bacterial infections, chemicals, malignancy, and medications. Particular attention should be paid to the onset, timing, and severity as they can indicate the underlying cause. In cases of iatrogenic-induced pancytopenia, the offending agent should be stopped immediately and the patient should be monitored for recovery of cell lines. While not well reported in the literature, trimethoprim-sulfamethoxazole (TMP-SMX) is a cause of pancytopenia. We present a case of drug-induced pancytopenia secondary to TMP-SMX that resolved quickly with cessation of use.
Insights
Pancytopenia, a drop in blood cell counts, can stem from various causes. This case highlights trimethoprim-sulfamethoxazole (TMP-SMX) as a potential drug-induced pancytopenia trigger, resolving upon discontinuation.
Area of Science:
- Hematology
- Pharmacology
- Internal Medicine
Background:
- Pancytopenia is a significant hematological condition characterized by a reduction in all three major blood cell lines.
- Etiologies are diverse, encompassing infections, toxins, malignancy, and medications.
- Identifying the cause is crucial for timely and effective management.
Observation:
- A case of pancytopenia was observed.
- The patient was administered trimethoprim-sulfamethoxazole (TMP-SMX).
- The onset, timing, and severity suggested an iatrogenic cause.
Findings:
- Drug-induced pancytopenia secondary to TMP-SMX was diagnosed.
- Cessation of TMP-SMX led to rapid recovery of hematological cell lines.
- TMP-SMX is an underreported cause of drug-induced pancytopenia.
Implications:
- Clinicians should consider TMP-SMX as a potential cause of pancytopenia.
- Prompt discontinuation of the offending agent is key for patient recovery.
- Further investigation into TMP-SMX's hematotoxicity is warranted.
More Related Videos
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Pharmacokinetics: Drug–Drug Interactions
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Vitamins

